ACCIUM BIOSCIENCES, INC.

Basic Information

550 17TH AVENUE
SUITE 550
SEATTLE, WA, 98122

Company Profile

n/a

Additional Details

Field Value
DUNS: 175977102
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Patient-specific therapy of glioblastoma using lightly-labeled [14C]-temozolomide

    Amount: $102,900.00

    DESCRIPTION (provided by applicant): It is widely accepted that the existing clinical paradigm of one treatment fits all is a major factor in the lack of progress in the effective treatment of a highl ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government